Medicinal chemistry services to support project "aldrich (univ. Of florida) - exploratory chemistry-admet only - mcsp"
Ended Awarded Last action
- Contract number
- 75N95023F00001
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $404,158
Award facts
- Opportunity
-
- NIHNINDS2301 Solicitation number
- Contract value 50% obligated
-
- $404,157.55 Current, with exercised options
- $815,714.07 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $259,807 | |
| Other Administrative Action | $0 | |
| Original award | $144,350 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri) for $815,714.07. The contract is for medicinal chemistry services to support the "ALDRICH (UNIV. OF FLORIDA) - EXPLORATORY CHEMISTRY-ADMET ONLY - MCSP" project, which is part of NINDS's Medicinal Chemistry Support Program for therapeutic development. Curia, a leading contract development and manufacturing organization, will provide a range of pharmaceutical research and development services including exploratory chemistry, absorption/distribution/metabolism/excretion (ADME) testing, and other support. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N95023F00001?
75N95023F00001 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 12, 2023.
How much is contract 75N95023F00001 worth?
The government has obligated $404,158 on 75N95023F00001. Its potential value, with all options, is $815,714.
Which agency awarded contract 75N95023F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023F00001, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95023F00001 an order under another contract?
Yes. 75N95023F00001 is a delivery order under HHSN271201800001I, an indefinite delivery contract.
Was contract 75N95023F00001 competed?
The extent of competition for 75N95023F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award